Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Oncology Pharma Inc. Oncology Pharma Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion Drug Delivery System July 12, 2022 From Oncology Pharma Inc. Via AccessWire Tickers ONPH Oncology Pharma Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery System June 29, 2022 From Oncology Pharma Inc. Via AccessWire Exposures Product Safety Tickers ONPH Oncology Pharma Announces: Initial Feasibility Study of the Nanoemulsion Drug Delivery System is Complete and Results Have Met the Threshold for Moving Forward To the Next Steps of Development June 08, 2022 From Oncology Pharma Inc. Via AccessWire Tickers ONPH Oncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial Development May 09, 2022 From Oncology Pharma Inc. Via AccessWire Tickers ONPH Oncology Pharma Completes Feasibility Phase of its Licensed Nanoemulsion Drug Delivery System to Treat Cancer April 13, 2022 From Oncology Pharma Inc. Via AccessWire Tickers ONPH Oncology Pharma Reports on Progress with Ribera Solutions March 02, 2022 From Oncology Pharma Inc. Via AccessWire Tickers ONPH Oncology Pharma Releases Further Feasibility Studies, Data and Capacities February 23, 2022 From Oncology Pharma Inc. Via AccessWire Tickers ONPH Oncology Pharma Expands on Feasibility Studies and Data February 17, 2022 From Oncology Pharma Inc. Via AccessWire Tickers ONPH Oncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer Vaccine February 14, 2022 From Oncology Pharma Inc. Via AccessWire Tickers ONPH RGBP RGBPP Oncology Pharma Gives Update on Technology, Formulation and Data Creation February 08, 2022 From Oncology Pharma Inc. Via AccessWire Tickers ONPH Oncology Pharma's New Year Update January 10, 2022 From Oncology Pharma Inc. Via AccessWire Tickers ONPH Oncology Pharma Meeting Towards Future Developments December 17, 2021 From Oncology Pharma Inc. Via AccessWire Tickers ONPH Oncology Pharma Year End Review and Outlook December 09, 2021 From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety Tickers ONPH Oncology Pharma Research and Vision November 30, 2021 From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety Tickers ONPH Oncology Pharma Reveals Plans for Development of Lead Cancer Drug Candidate November 08, 2021 From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety Tickers ONPH Oncology Pharma, Inc. Gives Update on Ongoing Work and Progress October 27, 2021 From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers ONPH Oncology Pharma, Inc. Has Engaged a PCAOB Audit Firm Looking Towards Moving the Company Towards a Senior Listing October 15, 2021 From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures Intellectual Property Legal Regulatory Tickers ONPH Oncology Pharma, Inc. Update on PCAOB Audit Selection Process and License Agreement October 12, 2021 From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers ONPH Oncology Pharma, Inc. Has Received the Committed Funding to Perform All Necessary IND-Enabling Preclinical Work for Its First Lead Candidate, a Dactinomycin Nanoemulsion Drug Product September 13, 2021 From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety Tickers ONPH Oncology Pharma's Co-Development Agreement Pursues Strategic and Direct Objectives August 23, 2021 From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety Tickers ONPH Oncology Pharma, Inc. Executes Co-Development Agreement with NanoSmart Pharmaceuticals, Inc. August 19, 2021 From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety Tickers ONPH Oncology Pharma, Inc. To Move to Conducting Trials on Licensed IP July 20, 2021 From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers ONPH Oncology Pharma, Inc. is Entering Into the Next Phase of its Growth and Expansion Phase June 30, 2021 From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety Tickers ONPH Oncology Pharma, Inc. Eyes Collaboration with Patent Opportunities Amongst Its Licensed Intellectual Properties June 15, 2021 From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers ONPH Oncology Pharma and Ribera Solutions Release White Paper Regarding Patient Engagement and Retention Platform June 09, 2021 From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers ONPH Oncology Pharma, Inc. Is Pursuing the Development of Its Small Molecule Drug for the Treatment of Colon Cancer May 18, 2021 From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers ONPH Oncology Pharma, Inc. Has Submitted Its Initial Application to List the Company on the Capital Markets Tier of the NASDAQ Exchange May 12, 2021 From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers ONPH Oncology Pharma Enters into License Agreement for Small Molecules Intellectual Property for the Treatment of Colon Cancer May 07, 2021 From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers ONPH Oncology Pharma, Inc. Prepares Plan Toward Funding Development and Implementation of Ribera Solutions' Patient Engagement and Retention Platform April 21, 2021 From Oncology Pharma Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers ONPH Oncology Pharma, Inc. Addresses Pancreatic Cancer, the Need for an Effective Therapy and the Potential of mRNA Technology April 14, 2021 From Oncology Pharma Inc. Via AccessWire Topics Death Intellectual Property Exposures Death Intellectual Property Tickers ONPH Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.